{"id":399727,"date":"2025-06-01T01:05:00","date_gmt":"2025-05-31T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=399727"},"modified":"2025-06-01T01:14:13","modified_gmt":"2025-05-31T23:14:13","slug":"efeito-secundario-raro-da-terapeutica-com-tirzepatide","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/efeito-secundario-raro-da-terapeutica-com-tirzepatide\/","title":{"rendered":"Efeito secund\u00e1rio raro da terap\u00eautica com tirzepatide"},"content":{"rendered":"\n<p><strong>O triazepatide, agonista duplo do polipept\u00eddeo insulinotr\u00f3pico dependente da glicose (GIP)\/recetor do pept\u00eddeo 1 semelhante ao glucagon (GLP1), mostrou-se promissor para melhorar o controlo glic\u00e9mico e a perda de peso. No entanto, tamb\u00e9m pode ter efeitos secund\u00e1rios indesej\u00e1veis. M\u00e9dicos de Abu Dhabi apresentaram um caso de hepatotoxicidade causada por tirzepatide e sublinharam a import\u00e2ncia da monitoriza\u00e7\u00e3o cl\u00ednica durante o tratamento com tirzepatide.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fefeito-secundario-raro-da-terapeutica-com-tirzepatide%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>O triazepatide, agonista duplo do polipept\u00eddeo insulinotr\u00f3pico dependente da glicose (GIP)\/recetor do pept\u00eddeo 1 semelhante ao glucagon (GLP1), mostrou-se promissor para melhorar o controlo glic\u00e9mico e a perda de peso&#8230;.&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fefeito-secundario-raro-da-terapeutica-com-tirzepatide%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":399729,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Relato de caso: Hepatite induzida por medicamentos  ","footnotes":""},"category":[11536,11397,11521,11453,11524,11407,11551],"tags":[13335,25237,42080,82619,50213,16142,72458],"powerkit_post_featured":[],"class_list":["post-399727","post","type-post","status-publish","format-standard","has-post-thumbnail","category-casos-pt-pt","category-endocrinologia-e-diabetologia-2","category-estudos","category-farmacologia-e-toxicologia","category-formacao-continua","category-gastroenterologia-e-hepatologia","category-rx-pt","tag-casuistica-pt-pt","tag-controlo-do-acucar-no-sangue","tag-efeito-colateral","tag-gip-glp1-ra-pt-pt","tag-hepatotoxicidade","tag-reducao-de-peso","tag-tirzepatide-pt-pt","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-20 14:56:14","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":399712,"slug":"efecto-secundario-poco-frecuente-de-la-terapia-con-tirzepatida","post_title":"Efecto secundario poco frecuente de la terapia con tirzepatida","href":"https:\/\/medizinonline.com\/es\/efecto-secundario-poco-frecuente-de-la-terapia-con-tirzepatida\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/399727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=399727"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/399727\/revisions"}],"predecessor-version":[{"id":399731,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/399727\/revisions\/399731"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/399729"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=399727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=399727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=399727"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=399727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}